Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
Matthews DR, et al. • Diabetologia
Key Finding
The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by the euglycaemic clamp (Rs = 0.88, P less than 0.0001)
Key Findings
- 1Insulin resistance estimate correlates with euglycaemic clamp: Rs = 0.88 (P < 0.0001)
- 2Beta-cell function estimate correlates with hyperglycaemic clamp: Rs = 0.61 (P < 0.01)
- 3Model coefficient of variation similar to clamp methods: 31-32%
Original title: “Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man”
Plain English Summary
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia.
In-Depth Analysis
Abstract (verbatim from original paper)
"The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia."
Key Statistics (from original paper)
- •Insulin resistance vs euglycaemic clamp: Rs = 0.88 (P < 0.0001)
- •Beta-cell function vs hyperglycaemic clamp: Rs = 0.61 (P < 0.01)
- •Coefficient of variation (IR estimate): 31%
- •Coefficient of variation (β-cell estimate): 32%
Authors' Conclusion
"The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test."
"The low variability of the estimates from the model (coefficient of variation: 31% and 32% respectively) is similar to that of the hyperglycaemic and euglycaemic clamp methods."
Note: This content is derived from the PubMed abstract (PMID 3899825). Full text is not freely available as this 1985 paper predates the PMC archive.
Paradigm Relevance
How this study applies to different clinical perspectives:
Standard Medical
RelevantConventional clinical guidelines used by most doctors
Research Consensus
RelevantCurrent scientific understanding, often ahead of guidelines
Metabolic Optimization
RelevantProactive targets for optimal health, not just disease absence
Study Details
- Type
- Landmark Study
- Methodology
- Computer-solved model validated against hyperglycaemic and euglycaemic clamps and intravenous glucose tolerance test. Coefficients of variation: 31% (insulin resistance) and 32% (beta-cell function).
Evidence Quality
Foundational derivation study. Validated in subsequent research globally. Note: Full text not available in PMC (predates archive). Content sourced from PubMed abstract only.
Related Biomarkers
Calculate & Evaluate on Metabolicum
Original Source
DOI (Digital Object Identifier) is a permanent link to this publication. Unlike website URLs that can change, a DOI always resolves to the correct source.
Related Studies
Freeman 2023: Insulin Resistance - Clinical Overview
Freeman et al. • StatPearls Publishing • 2023
HOMA-IR is the most practical clinical tool for assessing insulin resistance
Insights from a general practice service evaluation supporting a lower carbohydrate diet in patients with type 2 diabetes mellitus and prediabetes: a secondary analysis of routine clinic data including HbA1c, weight and prescribing over 6 years
Unwin et al. • BMJ Nutrition, Prevention & Health • 2020
T2D drug-free remission: 46% (59/128); HbA1c 65.5→48 mmol/mol (P<0.001); weight 99.7→91.4 kg; prediabetes: 93% normalized HbA1c; £50,885/year prescription savings
Sutton 2018: Time-Restricted Eating Improves Insulin Sensitivity
Sutton et al. • Cell Metabolism • 2018
Early 6-hour eating window improved insulin sensitivity by 36% without weight loss